KKR agreed to acquire Integer Holdings for $5.7 billion in all-cash, taking private a medical equipment manufacturer whose revenue base runs through cardiac rhythm management, neuromodulation, and portable medical systems. The deal values Integer at a point where surgical component demand is recovering but capital allocation in hospitals remains uneven.
Integer manufactures components and finished devices for implantable systems—pacemakers, defibrillators, neurostimulators—and portable oxygen concentrators. Revenue for fiscal 2025 came in near $1.55 billion, up 6% year-over-year, with gross margin holding at 27.8% despite raw material volatility and labor cost inflation in its Swiss and Mexican facilities. The company services more than 400 OEM customers, including all major cardiac device manufacturers, and holds long-term supply agreements that smooth revenue but compress pricing power. KKR is betting that operational leverage and contract renegotiation under private ownership can push EBITDA margin from the current 18% toward the low twenties within thirty-six months.
This is KKR's second medical equipment platform in eighteen months, following its $3.8 billion take-private of Cotiviti's healthcare analytics arm in early 2025. The firm has allocated roughly $14 billion to healthcare since 2023, with a tilt toward capital-light services and capital-heavy manufacturing where margin expansion is executable through procurement centralization and facility consolidation. Integer's exposure to elective procedures—roughly 40% of revenue ties to non-urgent implants—gives KKR a bet on procedure volume normalization as U.S. hospital admissions for cardiac and neuro cases recover to pre-2024 baselines. The all-cash structure signals confidence that Integer's free cash flow conversion, running near 85%, can service the leverage load without equity dilution or earn-out complexity.
The takeout removes a publicly traded pure-play from the medical component supply chain at a moment when device OEMs are consolidating supplier rosters. Integer's largest customers have been reducing component vendors by 15-20% since 2024, favoring scale players who can meet FDA traceability requirements and absorb cost volatility. Private ownership gives Integer the runway to invest in capacity without quarterly earnings pressure, particularly in its Swiss neuromodulation line, which has been capacity-constrained since mid-2025. KKR's prior work in medical manufacturing—Envision Healthcare, Air Medical—suggests a playbook: cut SKU count by 20-30%, rationalize underperforming facilities, renegotiate raw material contracts, and prepare for a secondary exit to a strategic acquirer or another sponsor within five to seven years.
Operators should watch for two follow-on events. First, whether KKR moves to consolidate Integer with other portfolio assets in adjacent medical component categories, which would create pricing leverage with shared OEM customers. Second, whether device OEMs accelerate their own M&A to bring component manufacturing in-house, a trend that has been building since Abbott and Medtronic both acquired smaller suppliers in 2024 and 2025. If that happens, Integer's valuation as a takeout candidate for a strategic buyer would reset higher, potentially giving KKR an exit inside four years.
The deal closes in Q4 2026, subject to regulatory clearance and Integer shareholder approval. KKR is financing with $2.9 billion in committed debt from JPMorgan and BofA, implying leverage near 5.1x trailing EBITDA, tight but not aggressive for a business with high cash conversion and long-term customer contracts.
The takeaway
KKR bets $5.7B that Integer's supplier position and margin structure can carry leverage while device OEMs consolidate vendors.
Want the 60-second program for your specific event?
Enter your event and email — we build it and send the branded proposal before lunch. No obligation.
The branded-identity layer Chiefs of Staff and heritage CMOs route through — your name imprinted on real authorized stock, your pick of 200+ brands and 70,000 products, shipped from one accountable house. Nine editorial desks publish the intelligence those operators read before they sign.
200+authorized brands
70,000products · virtual proof on each
9 deskspublishing daily
1997one house, since
70,000 SKUs · virtual proof in 60 seconds · no platform fee · blind-shipped · ASI #217876
Your next customer won't visit your website. Their AI will.
AI assistants have quietly taken over the first step of buying — they answer from catalogs they can read and shortlist whoever can actually ship. Two questions now decide whether you exist to that buyer: can a machine read your catalog, and can you fulfill the order. Most brands fail one or both and never find out why the orders went elsewhere. The winners of this shift aren't the loudest. They're the most readable. Build for the machine that's about to do the shopping.
Built by the craft floor — apparel, media, packaging, and secure print.
This trade runs on hands, not desks. Imprint manufacturing & Komori heritage press through approved vendors · Canon high-speed secure-media operations is a craft floor — genuine Six Sigma discipline applied to ink, thread, foil, and registration, where a hundredth of an inch is the difference between a brand that reads serious and one that reads cheap. POPS4 is built by exactly those operators: independent, boots-on-the-ground engineers who carry their own book, read a client in microseconds, and put their name on every run. Beyond our own Virginia Beach floor, we work with a vetted network of craft manufacturers across the US — each meeting the highest excellence in QC standards in the industry, each a specialist in its own discipline — so apparel, hard-goods imprinting, media manufacturing, packaging, and secure printing all go to the bench built for them, coordinated from one accountable hub. Short-run from twenty-five units, volume to five hundred thousand. Two hundred authorized national brands, seventy thousand SKUs with virtual proofing on every one. Art archived for instant reorders. Net-thirty corporate terms, NDA-standard white-label — your name on the work, or none at all.
Strategy, positioning, identity, creative, and messaging — wired into an AI system that publishes and distributes on its own. Nine editorial desks generate the authority, the production house ships the physical proof, and the attribution layer tells you which post sold which SKU. What you get is an operating layer — content, catalog, and order path under one roof — that keeps working whether or not you are in the room. Built for principals who would rather own the machine than rent the agency.
Named-account programs — one desk, quiet delivery, NDA-standard.
One point of contact who already knows the file, so nothing restarts from zero between engagements. The work ships blind, under NDA, with your name on it or none at all. Built for single-family offices, heritage-house CMOs, sports-ownership groups, and the agencies that white-label our production. The relationship is the product; the merch is the proof of it.
SFO · Chief of Staff desk. Principal household, properties, aircraft, yacht, calendar, philanthropy — one file.
Shop seventy thousand products. Virtual proof on every one. 24/7.
Drop your logo on any product and see the virtual proof before asking. Quote routes direct to the desk. MCP catalog for AI agents. Celeste for the fast conversation. Full self-service checkout in development.